← Back to Search

Sleep Enhancement and Health Education for High Blood Pressure

N/A
Waitlist Available
Led By Virend Somers, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 18 to 65 (inclusive)
Be older than 18 years old
Must not have
Travel across >2 time zones in the previous month
Severe daytime sleepiness (score >15 at the Epworth Sleepiness Scale)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks

Summary

This trial will compare the effects of 8 weeks of sleep enhancement/extension vs health education in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep (≤6.5 hours/night).

Who is the study for?
This trial is for adults aged 18-65 with prehypertension or stage 1 hypertension who usually sleep less than 7 hours a night. They should not be on varying medications, pregnant, breastfeeding, smoking, or have serious health issues like heart disease or diabetes. Participants must also not consume excessive alcohol or caffeine.
What is being tested?
The study compares the effects of an 8-week program focused on improving sleep habits versus providing health education to individuals with high blood pressure who typically don't get enough sleep.
What are the potential side effects?
Since the interventions involve non-pharmaceutical measures (sleep enhancement and health education), significant side effects are not anticipated. However, changes in sleep patterns can sometimes affect mood and alertness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not traveled across more than 2 time zones in the last month.
Select...
I often feel very sleepy during the day.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
change in 48-hour mean arterial pressure
Secondary study objectives
changes in 48-hour heart rate
changes in aldosterone
changes in angiotensin peptides
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sleep EnhancementExperimental Treatment1 Intervention
Group II: Health EducationPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,938 Previous Clinical Trials
47,792,243 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,060,968 Total Patients Enrolled
Virend Somers, MD, PhDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus
9 Previous Clinical Trials
5,320 Total Patients Enrolled

Media Library

Health Education Clinical Trial Eligibility Overview. Trial Name: NCT03255746 — N/A
High Blood Pressure Research Study Groups: Sleep Enhancement, Health Education
High Blood Pressure Clinical Trial 2023: Health Education Highlights & Side Effects. Trial Name: NCT03255746 — N/A
Health Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT03255746 — N/A
~7 spots leftby Dec 2025